80 related articles for article (PubMed ID: 30458859)
1. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
Langerud J; Jarhelle E; Van Ghelue M; Ariansen SL; Iversen N
Hum Genomics; 2018 Nov; 12(1):51. PubMed ID: 30458859
[TBL] [Abstract][Full Text] [Related]
2. Functional evaluation of BRCA1/2 variants of unknown significance with homologous recombination assay and integrative in silico prediction model.
Guo Q; Ji S; Takeuchi K; Urasaki W; Suzuki A; Iwasaki Y; Saito H; Xu Z; Arai M; Nakamura S; Momozawa Y; Chiba N; Miki Y; Matsuura M; Sunada S
J Hum Genet; 2023 Dec; 68(12):849-857. PubMed ID: 37731132
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 Circos: a visualisation resource for functional analysis of missense variants.
Jhuraney A; Velkova A; Johnson RC; Kessing B; Carvalho RS; Whiley P; Spurdle AB; Vreeswijk MP; Caputo SM; Millot GA; Vega A; Coquelle N; Galli A; Eccles D; Blok MJ; Pal T; van der Luijt RB; Santamariña Pena M; Neuhausen SL; Donenberg T; Machackova E; Thomas S; Vallée M; Couch FJ; Tavtigian SV; Glover JN; Carvalho MA; Brody LC; Sharan SK; Monteiro AN;
J Med Genet; 2015 Apr; 52(4):224-30. PubMed ID: 25643705
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for
Innella G; Ferrari S; Miccoli S; Luppi E; Fortuno C; Parsons MT; Spurdle AB; Turchetti D
J Med Genet; 2024 Apr; 61(5):483-489. PubMed ID: 38160042
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain.
Hu C; Huang H; Na J; Lumby C; Abozaid M; Holdren MA; Rao TJ; Karam R; Pesaran T; Weyandt JD; Csuy CM; Seelaus CA; Young CC; Fulk K; Heidari Z; Morais Lyra PC; Couch RE; Persons B; Polley EC; Gnanaolivu RD; Boddicker NJ; Monteiro ANA; Yadav S; Domchek SM; Richardson ME; Couch FJ
Am J Hum Genet; 2024 Mar; 111(3):584-593. PubMed ID: 38417439
[TBL] [Abstract][Full Text] [Related]
6. Inter-BRCT linker is probably the most intolerant region of the BRCA1 BRCT domain.
Yadegari F; Farahmand L; Esmaeili R; Zarinfam S; Majidzadeh-A K
J Biomol Struct Dyn; 2023 Nov; ():1-13. PubMed ID: 37948190
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 frameshift variants leading to extended incorrect protein C termini.
Nepomuceno TC; Foo TK; Richardson ME; Ranola JMO; Weyandt J; Varga MJ; Alarcon A; Gutierrez D; von Wachenfeldt A; Eriksson D; Kim R; Armel S; Iversen E; Couch FJ; Borg Å; Xia B; Carvalho MA; Monteiro ANA
HGG Adv; 2023 Oct; 4(4):100240. PubMed ID: 37718511
[TBL] [Abstract][Full Text] [Related]
8. Toward classification of BRCA1 missense variants using a biophysical approach.
Rowling PJ; Cook R; Itzhaki LS
J Biol Chem; 2010 Jun; 285(26):20080-7. PubMed ID: 20378548
[TBL] [Abstract][Full Text] [Related]
9. A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: application to
Zanti M; O'Mahony DG; Parsons MT; Li H; Dennis J; Aittomäkkiki K; Andrulis IL; Anton-Culver H; Aronson KJ; Augustinsson A; Becher H; Bojesen SE; Bolla MK; Brenner H; Brown MA; Buys SS; Canzian F; Caputo SM; Castelao JE; Chang-Claude J; ; Czene K; Daly MB; De Nicolo A; Devilee P; Dörk T; Dunning AM; Dwek M; Eccles DM; Engel C; Evans DG; Fasching PA; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Gentry-Maharaj A; Geurts-Giele WRR; Giles GG; Glendon G; Goldberg MS; Garcia EBG; Güendert M; Guénel P; Hahnen E; Haiman CA; Hall P; Hamann U; Harkness EF; Hogervorst FBL; Hollestelle A; Hoppe R; Hopper JL; Houdayer C; Houlston RS; Howell A; ; Jakimovska M; Jakubowska A; Jernström H; John EM; Kaaks R; Kitahara CM; Koutros S; Kraft P; Kristensen VN; Lacey JV; Lambrechts D; Léoné M; Lindblom A; Lubiński J; Lush M; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Martinez ME; Menon U; Milne RL; Monteiro AN; Murphy RA; Neuhausen SL; Nevanlinna H; Newman WG; Offit K; Park SK; James P; Peterlongo P; Peto J; Plaseska-Karanfilska D; Punie K; Radice P; Rashid MU; Rennert G; Romero A; Rosenberg EH; Saloustros E; Sandler DP; Schmidt MK; Schmutzler RK; Shu XO; Simard J; Southey MC; Stone J; Stoppa-Lyonnet D; Tamimi RM; Tapper WJ; Taylor JA; Teo SH; Teras LR; Terry MB; Thomassen M; Troester MA; Vachon CM; Vega A; Vreeswijk MPG; Wang Q; Wappenschmidt B; Weinberg CR; Wolk A; Zheng W; Feng B; Couch FJ; Spurdle AB; Easton DF; Goldgar DE; Michailidou K
Hum Mutat; 2023; 2023():. PubMed ID: 38725546
[TBL] [Abstract][Full Text] [Related]
10. Multiplexed assay of variant effect reveals residues of functional importance in the BRCA1 coiled-coil and serine cluster domains.
Nagy G; Diabate M; Banerjee T; Adamovich AI; Smith N; Jeon H; Dhar S; Liu W; Burgess K; Chung D; Starita LM; Parvin JD
PLoS One; 2023; 18(11):e0293422. PubMed ID: 37917606
[TBL] [Abstract][Full Text] [Related]
11. Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variant.
Block I; Mateu-Regué À; Do TTN; Miceikaite I; Sdogati D; Larsen MJ; Hao Q; Nielsen HR; Boonen SE; Skytte AB; Jensen UB; Høffding LK; De Nicolo A; Viel A; Tudini E; Parsons MT; Hansen TVO; Rossing M; Kruse TA; Spurdle AB; Thomassen M
Breast Cancer Res; 2024 Jan; 26(1):6. PubMed ID: 38195559
[TBL] [Abstract][Full Text] [Related]
12. Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C.
Hu C; Nagaraj AB; Shimelis H; Montalban G; Lee KY; Huang H; Lumby CA; Na J; Susswein LR; Roberts ME; Marshall ML; Hiraki S; LaDuca H; Chao E; Yussuf A; Pesaran T; Neuhausen SL; Haiman CA; Kraft P; Lindstrom S; Palmer JR; Teras LR; Vachon CM; Yao S; Ong I; Nathanson KL; Weitzel JN; Boddicker N; Gnanaolivu R; Polley EC; Mer G; Cui G; Karam R; Richardson ME; Domchek SM; Yadav S; Hruska KS; Dolinsky J; Weroha SJ; Hart SN; Simard J; Masson JY; Pang YP; Couch FJ
Cancer Res; 2023 Aug; 83(15):2557-2571. PubMed ID: 37253112
[TBL] [Abstract][Full Text] [Related]
13. DNA repair function scores for 2172 variants in the BRCA1 amino-terminus.
Diabate M; Islam MM; Nagy G; Banerjee T; Dhar S; Smith N; Adamovich AI; Starita LM; Parvin JD
PLoS Genet; 2023 Aug; 19(8):e1010739. PubMed ID: 37578980
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patients.
Henkel J; Laner A; Locher M; Wohlfrom T; Neitzel B; Becker K; Neuhann T; Abicht A; Steinke-Lange V; Holinski-Feder E
Eur J Hum Genet; 2023 Aug; 31(8):925-930. PubMed ID: 37188824
[TBL] [Abstract][Full Text] [Related]
15. Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriers.
Gracia B; Montes P; Gutierrez AM; Arun B; Karras GI
Cell Rep; 2024 Feb; 43(2):113803. PubMed ID: 38368609
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer.
Ismail T; Alzneika S; Riguene E; Al-Maraghi S; Alabdulrazzak A; Al-Khal N; Fetais S; Thanassoulas A; AlFarsi H; Nomikos M
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543119
[TBL] [Abstract][Full Text] [Related]
17. Reassessment of the NF1 variants of unknown significance found during the 20-year activity of a genetics diagnostic laboratory.
Martorana D; Barili V; Uliana V; Ambrosini E; Riva M; De Sensi E; Luppi E; Messina C; Caleffi E; Pisani F; Percesepe A
Eur J Med Genet; 2023 Nov; 66(11):104847. PubMed ID: 37751797
[TBL] [Abstract][Full Text] [Related]
18. Protein-Folding Chaperones Predict Structure-Function Relationships and Cancer Risk in
Gracia B; Montes P; Gutierrez AM; Arun B; Karras GI
bioRxiv; 2023 Sep; ():. PubMed ID: 37745493
[TBL] [Abstract][Full Text] [Related]
19. A New Set of in Silico Tools to Support the Interpretation of ATM Missense Variants Using Graphical Analysis.
Porras LM; Padilla N; Moles-Fernández A; Feliubadaló L; Santamariña-Pena M; Sánchez AT; López-Novo A; Blanco A; de la Hoya M; Molina IJ; Osorio A; Pineda M; Rueda D; Ruiz-Ponte C; Vega A; Lázaro C; Díez O; Gutiérrez-Enríquez S; de la Cruz X
J Mol Diagn; 2024 Jan; 26(1):17-28. PubMed ID: 37865290
[TBL] [Abstract][Full Text] [Related]
20. Predicting pathogenicity of missense variants with weakly supervised regression.
Cao Y; Sun Y; Karimi M; Chen H; Moronfoye O; Shen Y
Hum Mutat; 2019 Sep; 40(9):1579-1592. PubMed ID: 31144781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
